Wire Stories
560InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-332 Meet Primary Endpoint in Patients with Atomic Dermatitis
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today...
- 823
FARFETCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Farfetch Limited and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has...
- 477
PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found PADCEV plus pembrolizumab nearly doubled median overall...
- 432
CORRECTING and REPLACING Aurora, PTT Station, and Royal Umbrella are among the Winners of the 2023 – 2024 World Branding Awards
LONDON–(BUSINESS WIRE)–#worldbranding–Fourth paragraph, first sentence of release dated December 8, 2023, should read: Winners from Thailand include Thai Life Insurance, PTT Station,...
- 496
MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023
HANGZHOU, China–(BUSINESS WIRE)–MOGU Inc. (NYSE: MOGU) (“MOGU†or the “Companyâ€), a KOL-driven online fashion and lifestyle destination in China, today announced its...
- 833
Global Manufacturing Execution Systems (MES) Strategic Market Report, 2022 and 2023-2030: Rapidly Changing Dynamics in the Process & Discrete Manufacturing Environments Necessitate MES Deployments – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Manufacturing Execution Systems (MES) – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. Global Manufacturing Execution Systems (MES)...
- 586
Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an up to Once-Monthly Facilitated Subcutaneous At-Home or...
- 459
U.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)
HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCRâ€) announced that the U.S. Food and Drug Administration...
- 434
Rocket Lab Reaches New Annual Launch Record with 10th Electron Mission This Year
The mission successfully deployed a satellite for Japan-based Earth imaging company Institute for Q-shu Pioneers of Space, Inc LONG BEACH, Calif. &...
- 406
 Elliptic Labs Launches with Vivo S18 and S18 Pro Smartphones
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorsâ„¢ currently deployed...
